Article Text

Download PDFPDF
A case of neonatal eustachian valve endocarditis
  1. Celia Chu1,
  2. Dean Wallace2,
  3. Bibian N Ofoegbu2,
  4. Ibrahim Hassan1
  1. 1Department of Microbiology, University Hospital South Manchester NHS Foundation Trust, Manchester, UK
  2. 2Neonatal Intensive Care Unit, University Hospital South Manchester NHS Foundation Trust, Manchester, UK
  1. Correspondence to Dr Celia Chu, Specialty Trainee in Microbiology, University Hospital South Manchester NHS Foundation Trust, Wythenshawe Hospital, Southmoor Road, Wythenshawe, Manchester M23 9LT, UK; celiachu{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

An extremely low birthweight neonate, born at 23 weeks' gestation weighing 600 g, developed eustachian valve endocarditis as a complication of neonatal intensive care. In addition to the presence of intraumbilical lines and percutaneous long lines, there was also evidence of maternal chorioamnionitis. Current first-line therapies for presumed infection on this neonatal unit are amoxicillin and gentamicin usually given for up to 5 days. By the third week of life, following clinical deterioration, rising infection markers (C reactive protein and white cell count), a fall in platelets and three serial blood cultures positive for Staphylococcus haemolyticus, endocarditis was suspected. A diagnosis of endocarditis was confirmed on echocardiography to involve the eustachian valve (figure 1).

Figure 1

Echocardiogram showing bulkiness of septum (arrowed) secondary to eustachian valve vegetation.

The eustachian valve is an embryological remnant found at the insertion of the inferior vena cava into the right atrium. It directs fetal blood towards the left atrium through the foramen ovale. It is infrequently visualised in adults …

View Full Text


  • Competing interests None.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.